Is It Time to Shift the Monotherapy After Percutaneous Coronary Intervention From Aspirin to P2Y12 Inhibitors?　― New Normal in the New-Generation Era ―

Masahiro Natsuaki; Koichi Node

doi:10.1253/circj.CJ-21-0026

Circulation Journal

Online ISSN : 1347-4820
Print ISSN : 1346-9843
ISSN-L : 1346-9843

J-STAGE home
/
Circulation Journal
/
Volume 85 (2021) Issue 6
/
Article overview

Antithrombotic Therapy

Is It Time to Shift the Monotherapy After Percutaneous Coronary Intervention From Aspirin to P2Y₁₂ Inhibitors?　― New Normal in the New-Generation Era ―

Masahiro Natsuaki, Koichi Node

Author information

JOURNAL OPEN ACCESS FULL-TEXT HTML

2021 Volume 85 Issue 6 Pages 794-796

DOI https://doi.org/10.1253/circj.CJ-21-0026

Article (85-6 pp. 785-793)

Browse “Advance online publication” version

Details

Article 1st page

Content from these authors

This article is licensed under a Creative Commons [Attribution-NonCommercial-NoDerivatives 4.0 International] license.
https://creativecommons.org/licenses/by-nc-nd/4.0/

Favorites & Alerts